Serotonergic dystrophy induced by excess serotonin.
Administration of certain serotonin-releasing amphetamine derivatives (fenfluramine and/or 3,4-methylenedioxymethamphetamine, MDMA, 'ecstasy') results in dystrophic serotonergic morphology in the mammalian brain. In addition to drug administration, dystrophic serotonergic neurites are also associated with neurodegenerative disorders. We demonstrate here that endogenously elevated serotonin in the Drosophila CNS induces aberrant enlarged varicosities, or spheroids, that are morphologically similar to dystrophic mammalian serotonergic fibers. In Drosophila these spheroids are specific to serotonergic neurons, distinct from typical varicosities, and form only after prolonged increases in cytoplasmic serotonin. Our results also suggest that serotonin levels during early development determine later sensitivity of spheroid formation to manipulations of the serotonin transporter (SERT). Elevated serotonin also interacts with canonical protein aggregation and autophagic pathways to form spheroids. The data presented here support a model in which excess cytoplasmic neurotransmitter triggers a cell-specific pathway inducing aberrant morphology in fly serotonergic neurons that may be shared in certain mammalian pathologies.
Daubert
Elizabeth A
EA
Neuroscience Graduate Program, University of Virginia, Charlottesville, VA 22908, USA.
Heffron
Daniel S
DS
Mandell
James W
JW
Condron
Barry G
BG
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004331:Drosophila melanogaster / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism*; D005277:Fenfluramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D012701:Serotonin / Q000378:metabolism* / Q000494:pharmacology; D018490:Serotonin Agents / Q000378:metabolism / Q000494:pharmacology*; D019076:Transgenes
D018490:Serotonin Agents; D005277:Fenfluramine; D012701:Serotonin; D018817:N-Methyl-3,4-methylenedioxyamphetamine
J Neurosci. 1988 Aug;8(8):2788-803
2457659
J Pharmacol Exp Ther. 1989 Jun;249(3):928-43
2732954
J Neurosci. 2004 Apr 21;24(16):3899-906
15102905
Pharmacol Ther. 2009 Jan;121(1):89-99
19022290
Neuron. 2003 Jun 19;38(6):871-85
12818174
Science. 2001 Jul 27;293(5530):711-4
11408621
Lancet Neurol. 2007 Apr;6(4):352-61
17362839
Brain Res. 1990 Mar 12;511(1):165-8
2331614
J Neurosci. 1998 Jul 1;18(13):4854-60
9634551
Biol Psychiatry. 2003 Nov 15;54(10):953-9
14625137
J Neurosci. 2006 Aug 2;26(31):8057-68
16885219
Dev Biol. 1995 Jan;167(1):282-93
7851649
Nat Rev Neurosci. 2008 Nov;9(11):826-38
18931696
Eur J Neurosci. 2007 Jul;26(2):424-38
17650115
Dev Biol. 2005 Oct 1;286(1):207-16
16122730
Br J Pharmacol. 2001 Sep;134(1):46-57
11522596
Genes Brain Behav. 2007 Nov;6(8):756-69
17376153
Neurosci Lett. 1986 Jun 30;67(3):307-12
3461314
Mol Pharmacol. 2001 Jan;59(1):83-95
11125028
Mol Pharmacol. 1993 Dec;44(6):1227-31
7903417
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5950-5
12730384
J Neurochem. 2008 Aug;106(3):1426-39
18489716
Cell. 2003 Dec 26;115(7):851-62
14697203
J Neurosci. 2002 Oct 15;22(20):8942-50
12388601
CSH Protoc. 2007 Jun 01;2007:pdb.prot4771
21357109
J Neurosci Methods. 2009 May 15;179(2):300-8
19428541
Dev Biol. 2008 Aug 1;320(1):30-8
18561908
Ann N Y Acad Sci. 1990;600:649-61; discussion 661-4
1979216
Hum Mol Genet. 2006 Feb 1;15(3):433-42
16368705
Hum Mol Genet. 2008 Jan 15;17(2):170-8
17921520
Nat Cell Biol. 2003 Jun;5(6):566-71
12766776
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1817-21
1347426
Mol Psychiatry. 2005 Aug;10(8):782-9, 714
15940298
Neuron. 2003 Jul 17;39(2):217-25
12873380
Brain Res. 2008 Jun 27;1217:185-94
18502405
Cell. 2000 Mar 31;101(1):57-66
10778856
Arch Insect Biochem Physiol. 2005 May;59(1):12-31
15822093
J Neurosci. 1989 Aug;9(8):2866-77
2570137
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3777-81
15716359
J Neurosci. 2008 Dec 17;28(51):13805-14
19091971
Am J Pathol. 2007 Aug;171(2):513-24
17620365
Mol Psychiatry. 2006 Jan;11(1):99-113
16189511
Dev Dyn. 2008 Aug;237(8):2090-9
18627097
J Pharmacol Exp Ther. 2008 Jul;326(1):153-62
18400843
J Comp Neurol. 2009 Aug 1;515(4):441-53
19459220
Neurochem Res. 2006 Dec;31(12):1425-32
17086442
J Clin Invest. 2007 Jan;117(1):236-45
17173140
Nat Genet. 2007 May;39(5):678-82
17450142
Dev Cell. 2004 Aug;7(2):179-92
15296715
Curr Biol. 2006 Jun 6;16(11):1051-62
16753559
Science. 2004 Oct 29;306(5697):879-81
15514160
J Biol Chem. 2007 Feb 2;282(5):2918-28
17142836
J Comp Neurol. 1988 Feb 15;268(3):414-28
3129459
Curr Biol. 2007 Jan 9;17(1):1-11
17208179
Eur J Pharmacol. 2008 May 13;585(2-3):464-72
18417122
J Neurobiol. 2003 Mar;54(4):618-27
12555273
Synapse. 1998 Sep;30(1):62-70
9704882
J Neurochem. 2003 Oct;87(1):268-71
12969273
Curr Biol. 1999 Dec 2;9(23):1382-91
10607562
Neuron. 2009 Apr 30;62(2):218-29
19409267